Protective effect of KCl loading in gentamicin nephrotoxicity

J. R. Thompson, R. Simonsen, M. A. Spindler, P. M. Southern, R. E. Cronin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aminoglycoside nephrotoxicity in experimental animals can be reduced by calcium loading, inducing diabetes, and giving thyroid hormone, while a potassium deficient diet enhances aminoglycoside nephrotoxicity. This study investigated whether potassium loading protects against gentamicin nephrotoxicity in the rat. In part I, group GK ate a diet containing 3.5% potassium and drank 0.2 molΛ KCl. Pair-fed rats eating a standard diet, group G, ate a 1% potassium diet and drank water. After 10 days, each group received gentamicin subcutaneously, 60 mg/kg twice daily for 8 days. The control groups, K and C, received the high or normal potassium diet, respectively. To control for a protective effect from a high solute load, the effect of equimolar NaCl loading was studied in group GNa and Na. At the end of the 8 days of gentamicin, inulin clearance was significantly higher in GK compared with G (0.6 ± 0.1 v 0.3 ± 0.1 mL/min per 100 g body weight [BW], P < 0.05), but group GNa (0.4 ± 0.1 mL/min per 100 g BW) was not different from group G. Morphological studies demonstrated that potassium-loaded rats (group GK) had significantly less proximal tubular necrosis compared with rats on a standard potassium diet, group G. Sodium loading did not protect against cellular necrosis. Part II studied renal function, cortical Na,K-adenosine triphosphatase (ATPase) and gentamicin accumulation after 2 days of gentamicin to determine the early functional and biochemical effects of potassium loading before overt renal functional impairment. Gentamicin accumulation in the renal cortex was significantly reduced by potassium loading (1.6 ± 0.1 v 2.1 ± 0.1 μg/mg protein, P < 0.025), but was not reduced by sodium loading (1.8 ± 0.1 μg/mg protein). Thus, potassium loading diminished functional and histological evidence of gentamicin nephrotoxicity. The data suggest that reduced accumulation of gentamicin by the renal cortex of potassium-loaded animals is associated with and may be the mechanism of protection.

Original languageEnglish (US)
Pages (from-to)583-591
Number of pages9
JournalAmerican Journal of Kidney Diseases
Volume15
Issue number6
StatePublished - 1990

Fingerprint

Gentamicins
Potassium
Diet
Kidney
Aminoglycosides
Necrosis
Sodium
Body Weight
Inulin
Thyroid Hormones
Adenosine Triphosphatases
Proteins
Eating
Calcium
Control Groups
Water

ASJC Scopus subject areas

  • Nephrology

Cite this

Thompson, J. R., Simonsen, R., Spindler, M. A., Southern, P. M., & Cronin, R. E. (1990). Protective effect of KCl loading in gentamicin nephrotoxicity. American Journal of Kidney Diseases, 15(6), 583-591.

Protective effect of KCl loading in gentamicin nephrotoxicity. / Thompson, J. R.; Simonsen, R.; Spindler, M. A.; Southern, P. M.; Cronin, R. E.

In: American Journal of Kidney Diseases, Vol. 15, No. 6, 1990, p. 583-591.

Research output: Contribution to journalArticle

Thompson, JR, Simonsen, R, Spindler, MA, Southern, PM & Cronin, RE 1990, 'Protective effect of KCl loading in gentamicin nephrotoxicity', American Journal of Kidney Diseases, vol. 15, no. 6, pp. 583-591.
Thompson, J. R. ; Simonsen, R. ; Spindler, M. A. ; Southern, P. M. ; Cronin, R. E. / Protective effect of KCl loading in gentamicin nephrotoxicity. In: American Journal of Kidney Diseases. 1990 ; Vol. 15, No. 6. pp. 583-591.
@article{5762346315ea4fd180032c52621916e0,
title = "Protective effect of KCl loading in gentamicin nephrotoxicity",
abstract = "Aminoglycoside nephrotoxicity in experimental animals can be reduced by calcium loading, inducing diabetes, and giving thyroid hormone, while a potassium deficient diet enhances aminoglycoside nephrotoxicity. This study investigated whether potassium loading protects against gentamicin nephrotoxicity in the rat. In part I, group GK ate a diet containing 3.5{\%} potassium and drank 0.2 molΛ KCl. Pair-fed rats eating a standard diet, group G, ate a 1{\%} potassium diet and drank water. After 10 days, each group received gentamicin subcutaneously, 60 mg/kg twice daily for 8 days. The control groups, K and C, received the high or normal potassium diet, respectively. To control for a protective effect from a high solute load, the effect of equimolar NaCl loading was studied in group GNa and Na. At the end of the 8 days of gentamicin, inulin clearance was significantly higher in GK compared with G (0.6 ± 0.1 v 0.3 ± 0.1 mL/min per 100 g body weight [BW], P < 0.05), but group GNa (0.4 ± 0.1 mL/min per 100 g BW) was not different from group G. Morphological studies demonstrated that potassium-loaded rats (group GK) had significantly less proximal tubular necrosis compared with rats on a standard potassium diet, group G. Sodium loading did not protect against cellular necrosis. Part II studied renal function, cortical Na,K-adenosine triphosphatase (ATPase) and gentamicin accumulation after 2 days of gentamicin to determine the early functional and biochemical effects of potassium loading before overt renal functional impairment. Gentamicin accumulation in the renal cortex was significantly reduced by potassium loading (1.6 ± 0.1 v 2.1 ± 0.1 μg/mg protein, P < 0.025), but was not reduced by sodium loading (1.8 ± 0.1 μg/mg protein). Thus, potassium loading diminished functional and histological evidence of gentamicin nephrotoxicity. The data suggest that reduced accumulation of gentamicin by the renal cortex of potassium-loaded animals is associated with and may be the mechanism of protection.",
author = "Thompson, {J. R.} and R. Simonsen and Spindler, {M. A.} and Southern, {P. M.} and Cronin, {R. E.}",
year = "1990",
language = "English (US)",
volume = "15",
pages = "583--591",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Protective effect of KCl loading in gentamicin nephrotoxicity

AU - Thompson, J. R.

AU - Simonsen, R.

AU - Spindler, M. A.

AU - Southern, P. M.

AU - Cronin, R. E.

PY - 1990

Y1 - 1990

N2 - Aminoglycoside nephrotoxicity in experimental animals can be reduced by calcium loading, inducing diabetes, and giving thyroid hormone, while a potassium deficient diet enhances aminoglycoside nephrotoxicity. This study investigated whether potassium loading protects against gentamicin nephrotoxicity in the rat. In part I, group GK ate a diet containing 3.5% potassium and drank 0.2 molΛ KCl. Pair-fed rats eating a standard diet, group G, ate a 1% potassium diet and drank water. After 10 days, each group received gentamicin subcutaneously, 60 mg/kg twice daily for 8 days. The control groups, K and C, received the high or normal potassium diet, respectively. To control for a protective effect from a high solute load, the effect of equimolar NaCl loading was studied in group GNa and Na. At the end of the 8 days of gentamicin, inulin clearance was significantly higher in GK compared with G (0.6 ± 0.1 v 0.3 ± 0.1 mL/min per 100 g body weight [BW], P < 0.05), but group GNa (0.4 ± 0.1 mL/min per 100 g BW) was not different from group G. Morphological studies demonstrated that potassium-loaded rats (group GK) had significantly less proximal tubular necrosis compared with rats on a standard potassium diet, group G. Sodium loading did not protect against cellular necrosis. Part II studied renal function, cortical Na,K-adenosine triphosphatase (ATPase) and gentamicin accumulation after 2 days of gentamicin to determine the early functional and biochemical effects of potassium loading before overt renal functional impairment. Gentamicin accumulation in the renal cortex was significantly reduced by potassium loading (1.6 ± 0.1 v 2.1 ± 0.1 μg/mg protein, P < 0.025), but was not reduced by sodium loading (1.8 ± 0.1 μg/mg protein). Thus, potassium loading diminished functional and histological evidence of gentamicin nephrotoxicity. The data suggest that reduced accumulation of gentamicin by the renal cortex of potassium-loaded animals is associated with and may be the mechanism of protection.

AB - Aminoglycoside nephrotoxicity in experimental animals can be reduced by calcium loading, inducing diabetes, and giving thyroid hormone, while a potassium deficient diet enhances aminoglycoside nephrotoxicity. This study investigated whether potassium loading protects against gentamicin nephrotoxicity in the rat. In part I, group GK ate a diet containing 3.5% potassium and drank 0.2 molΛ KCl. Pair-fed rats eating a standard diet, group G, ate a 1% potassium diet and drank water. After 10 days, each group received gentamicin subcutaneously, 60 mg/kg twice daily for 8 days. The control groups, K and C, received the high or normal potassium diet, respectively. To control for a protective effect from a high solute load, the effect of equimolar NaCl loading was studied in group GNa and Na. At the end of the 8 days of gentamicin, inulin clearance was significantly higher in GK compared with G (0.6 ± 0.1 v 0.3 ± 0.1 mL/min per 100 g body weight [BW], P < 0.05), but group GNa (0.4 ± 0.1 mL/min per 100 g BW) was not different from group G. Morphological studies demonstrated that potassium-loaded rats (group GK) had significantly less proximal tubular necrosis compared with rats on a standard potassium diet, group G. Sodium loading did not protect against cellular necrosis. Part II studied renal function, cortical Na,K-adenosine triphosphatase (ATPase) and gentamicin accumulation after 2 days of gentamicin to determine the early functional and biochemical effects of potassium loading before overt renal functional impairment. Gentamicin accumulation in the renal cortex was significantly reduced by potassium loading (1.6 ± 0.1 v 2.1 ± 0.1 μg/mg protein, P < 0.025), but was not reduced by sodium loading (1.8 ± 0.1 μg/mg protein). Thus, potassium loading diminished functional and histological evidence of gentamicin nephrotoxicity. The data suggest that reduced accumulation of gentamicin by the renal cortex of potassium-loaded animals is associated with and may be the mechanism of protection.

UR - http://www.scopus.com/inward/record.url?scp=0025338443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025338443&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 583

EP - 591

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -